CCND2 and diffuse large B-cell lymphoma: Furthermore, Lossos et al. (2004) [13] proposed a complex of LMO2, FN1, BCL6, SCYA3, CCND2, and BCL2 as a suitable predictor in patients with DLBCL, independent of the International Prognostic Index (IPI).